Section Arrow
Quote
JUNS.NASDAQ
- Jupiter Neurosciences Inc
(Financial Status)
Quotes are at least 15-min delayed:2026/07/04 10:09 EDT
Regular Hours
Last
 0.223
+0.008 (+3.72%)
Day High 
0.2268 
Prev. Close
0.215 
1-M High
0.2982 
Volume 
1.51M 
Bid
0.2148
Ask
0.222
Day Low
0.2125 
Open
0.2218 
1-M Low
0.1954 
Market Cap 
10.37M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 0.23 
20-SMA 0.24 
50-SMA 0.29 
52-W High 3.33 
52-W Low 0.1721 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.26/-0.26
Enterprise Value
10.37M
Balance Sheet
Book Value Per Share
-0.06
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
21.80K
Operating Revenue Per Share
--
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
LIMNLiminatus Pharma Inc0.1425+0.0277+24.13%-- 
PPCBPropanc Biopharma Inc.1.77+0.33+22.92%0PE
RXRXRecursion Pharmaceuticals3.8+0.13+3.54%-- 
IOVAIovance Biotherapeutics4.31+0.34+8.56%-- 
SLSSELLAS Life Sciences Group14.98+1.71+12.89%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Jupiter Neurosciences Inc is a clinical-stage research and development company focused on developing treatments for neuroinflammation through the resveratrol platform. Its platform product, JOTROL, is an enhanced oral formulation of resveratrol, which has many potential indications. In the larger disease areas, which are targeting Parkinson's Disease. The group is presently in the process of conducting a Phase IIa clinical trial in Parkinson's Disease. The company operates through two reportable segments: premium nutritional supplements and pharmaceutical operations focused on drug candidates for CNS and rare orphan diseases. It generates the majority of its revenue from Premium Nutritional Supplements, which includes commercialization and sales of the Company's Nugevia product line.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.